During May and June 2025, hospitals and health departments in New York, Texas, and Wisconsin each reported a patient who became severely ill after self-injecting cosmetic botulinum toxin purchased online, according to a new CDC field report published in the agency's Morbidity and Mortality Weekly Report. None of the three patients met their state's legal requirements for purchasing or administering the substance, and investigators found no connection among them.
Botulinum neurotoxin, commonly known by brand names like Botox, is widely used by licensed medical professionals to temporarily reduce facial wrinkles. Even when FDA-approved products are administered by trained clinicians, the injections can occasionally cause localized paralytic side effects. But improperly sourced or administered products carry far greater risks.
The CDC report underscores a troubling pattern: consumers bypassing the medical system entirely to obtain and inject powerful neurotoxins at home. The products in these cases were not purchased from authorized distributors, and none of the patients had the professional credentials typically required to handle them.
While the full clinical details of each case are described in the report, the broader warning is clear. Botulinum toxin remains one of the most potent biological substances known, and even small dosing errors or contaminated formulations can lead to life-threatening complications, including difficulty breathing and widespread muscle paralysis. The cases add to a small but growing body of evidence that unregulated online sales of cosmetic injectables pose a serious public health concern.
